CARE Ratings informs about outcome of board meeting

05 Aug 2025 Evaluate

In compliance with regulation 30 and Para A of Part A of Schedule III of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (‘the Listing Regulations’), CARE Ratings has informed that the Board of Directors of the Company at their meeting held today, on Tuesday, August 5, 2025, have inter alia transacted the following businesses: 1. Considered and approved the Unaudited Standalone and Consolidated Financial Results ('Unaudited Financial Results') for the quarter ended June 30, 2025, along with Limited Review Report issued by B S R & Co. LLP, the Statutory Auditors of the Company. A copy of the Unaudited Financial Results together with the Limited Review Report on the said Unaudited Financial Results have been enclosed. 2. Approved reappointment of G. Mahalingam (DIN:09660723) as an Independent Director for a period of three years with effect from November 21, 2025, subject to approval of shareholders of the Company. 3. Approved reappointment of V. Chandrasekaran (DIN:03126243) as an Independent Director for a period of three years with effect from December 7, 2025, subject to approval of shareholders of the Company. Additional details pursuant to Regulation 30 and other relevant provisions of the Listing Regulations are enclosed as an Annexure A. The meeting of the Board of Directors of the Company commenced at 12:15 pm and concluded at 16:00 pm. The above information is also being made available on the Company’s website: www.careedge.in.

The above information is a part of company’s filings submitted to BSE.

Care Ratings Share Price

1543.90 8.90 (0.58%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
CRISIL 4451.65
ICRA 6081.05
Care Ratings 1543.90
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×